December 14, 2016 / 10:33 PM / 8 months ago

BRIEF-Ocular Therapeutix continues to prepare for resubmission to NDA for Dextenza

Dec 14 (Reuters) - Ocular Therapeutix Inc

* Continued to prepare for resubmission to NDA for DEXTENZA that co previously filed in Sept 2015 -SEC filing

* NDA resubmission is expected early in Q1 of 2017 following completion of testing of these commercial batches

* Plan is to include manufacturing records from recently completed commercial batches of Dextenza in NDA resubmission -SEC filing Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below